Guidelines for the therapeutic use of botulinum toxin in movement disorders

[1]  S Fahn,et al.  Development of resistance to botulinum toxin type A in patients with torticollis , 2004, Movement disorders : official journal of the Movement Disorder Society.

[2]  J. Jankovic,et al.  Botulinum toxin in the treatment of tics. , 2000, Archives of neurology.

[3]  A. Priori,et al.  Botulinum toxin treatment of muscle cramps: A clinical and neurophysiological study , 1997, Annals of neurology.

[4]  R. Sloop,et al.  Reconstituted Botulinum Toxin Type A Does Not Lose Potency in Humans If It Is Refrozen or Refrigerated for 2 Weeks Before Use , 1997, Neurology.

[5]  B. Bioulac,et al.  A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[6]  W Poewe,et al.  Botulinum toxin in writer's cramp: objective response evaluation in 31 patients. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[7]  B. Bhakta,et al.  Use of botulinum toxin in stroke patients with severe upper limb spasticity. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[8]  S. Fahn,et al.  Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients. , 1996, Archives of neurology.

[9]  A. Bentivoglio,et al.  Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[10]  J. Jankovic,et al.  A randomized, double‐blind, placebo‐controlled study to evaluate botulinum toxin type A in essential hand tremor , 1996, Movement disorders : official journal of the Movement Disorder Society.

[11]  D. M. Simpson,et al.  Botulinum toxin type A in the treatment of upper extremity spasticity , 1996, Neurology.

[12]  M. H. Prins,et al.  Botulinum toxin versus trihexyphenidyl in cervical dystonia , 1996, Neurology.

[13]  K. Arimura,et al.  Extrafusal and intrafusal muscle effects in experimental botulinum toxin‐A injection , 1996, Muscle & nerve.

[14]  J. Tew,et al.  Recurrence of hemifacial spasm after microvascular decompression. , 1996, Neurosurgery.

[15]  K. Mauritz,et al.  Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. , 1996, Stroke.

[16]  R. Illingworth,et al.  Hemifacial spasm: a prospective long-term follow up of 83 cases treated by microvascular decompression at two neurosurgical centres in the United Kingdom. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[17]  K. Mauritz,et al.  Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients , 1995, Neuroscience Letters.

[18]  A. Lees,et al.  Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[19]  J. Dunne,et al.  MATTERS ARISING , 1995 .

[20]  M. Aramideh,et al.  Pretarsal application of botulinum toxin for treatment of blepharospasm. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[21]  M. Hallett,et al.  Double‐Blind trial of botulinum toxin for treatment of focal hand dystonia , 1995, Movement disorders : official journal of the Movement Disorder Society.

[22]  G. Defazio,et al.  Botulinum a toxin for the so‐called apraxia of lid opening , 1995, Movement disorders : official journal of the Movement Disorder Society.

[23]  A. Berardelli,et al.  Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. , 1995, Brain : a journal of neurology.

[24]  B. Jabbari,et al.  Botulinum toxin A for spasticity, muscle spasms, and rigidity , 1995, Neurology.

[25]  M. Brin,et al.  Comparison of Therapeutic Efficacies of Type A and F Botulinum Toxins for Blepharospasm , 1995, Neurology.

[26]  H. Jho,et al.  Microvascular decompression for hemifacial spasm. , 1995, Journal of neurosurgery.

[27]  M. Brin,et al.  Laryngeal botulinum toxin injections for disabling stuttering in adults , 1994, Neurology.

[28]  M. Hallett,et al.  Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders , 1994, Neurology.

[29]  M. Maležič,et al.  Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[30]  L. Bour,et al.  Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm. , 1994, Brain : a journal of neurology.

[31]  A. Berardelli,et al.  Pathophysiology of hemimasticatory spasm. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[32]  M. Hallett,et al.  Long‐term botulinum toxin treatment of focal hand dystonia , 1994, Neurology.

[33]  I. Sanders,et al.  Quantifying how location and dose of botulinum toxin injections affect muscle paralysis , 1993, Muscle & nerve.

[34]  N. Bathien,et al.  Botulinum antibodies in dystonic patients treated with type A botulinum toxin , 1993, Neurology.

[35]  A. Berardelli,et al.  Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group , 1993, The Italian Journal of Neurological Sciences.

[36]  C. Marsden,et al.  The use of botulinum toxin in the treatment of adductor spasmodic dysphonia. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[37]  D. Calne,et al.  Botulinum toxin in the treatment of writer's cramp , 1993, Neurology.

[38]  R. Dengler,et al.  Local botulinum toxin in the treatment of spastic drop foot , 1992, Journal of Neurology.

[39]  J. Elston,et al.  A new variant of blepharospasm. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[40]  M. Brin,et al.  Abductor laryngeal dystonia: A series treated with botulinum toxin , 1992, The Laryngoscope.

[41]  A. Wiegner,et al.  Treatment of spasticity with botulinum toxin , 1992, Annals of neurology.

[42]  L. Blumhardt,et al.  A double blind trial of botulinum toxin "A" in torticollis, with one year follow up. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[43]  K. Schwartz,et al.  Botulinum toxin treatment of tremors , 1991, Neurology.

[44]  A. Aronson,et al.  Double‐blind controlled study of botulinum toxin in adductor spasmodic dysphonia , 1991, The Laryngoscope.

[45]  J. Jankovic,et al.  Therapeutic uses of botulinum toxin. , 1991, The New England journal of medicine.

[46]  D B Calne,et al.  Treatment of spasticity with botulinum toxin: A double‐blind study , 1990, Annals of neurology.

[47]  L. Wilkins.  Assessment: The clinical usefulness of botulinum toxin‐A in treating neurologic disorders , 1990, Neurology.

[48]  M. Brin,et al.  Double‐blind, placebo‐controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis , 1990, Neurology.

[49]  J. Jankovic,et al.  Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[50]  T. K. Das,et al.  Botulinum toxin in treating spasticity , 1989, The British journal of clinical practice.

[51]  D. Tk,et al.  Botulinum toxin in treating spasticity. , 1989 .

[52]  P. May,et al.  Morphological substrate for eyelid movements: Innervation and structure of primate levator palpebrae superioris and orbicularis oculi muscles , 1989, The Journal of comparative neurology.

[53]  M. Hallett,et al.  DOSE STANDARDISATION OF BOTULINUM TOXIN , 1989, The Lancet.

[54]  P. Thompson,et al.  Botulinum toxin treatment of spasmodic torticollis. , 1988, BMJ.

[55]  Á. Esteban,et al.  Involuntary closure of eyelids in parkinsonism Electrophysiological evidence for prolonged inhibition of the levator palpebrae muscles , 1988, Journal of the Neurological Sciences.

[56]  J Jankovic,et al.  Botulinum A toxin for cranial‐cervical dystonia , 1987, Neurology.

[57]  A. Eisen,et al.  DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLIS , 1986, The Lancet.

[58]  L. Simpson.  The origin, structure, and pharmacological activity of botulinum toxin. , 1981, Pharmacological reviews.

[59]  C. Marsden,et al.  Assessment of extrapyramidal disorders. , 1981, British journal of clinical pharmacology.

[60]  C. André,et al.  GASTRITIS VARIOLIFORMIS, ALLERGY, AND DISODIUM CROMOGLYCATE , 1976, The Lancet.

[61]  A. Aronson,et al.  Spastic dysphonia. II. Comparison with essential (voice) tremor and other neurologic and psychogenic dysphonias. , 1968, The Journal of speech and hearing disorders.

[62]  Bourdillon Jf.  PHENOTHIAZINE DYSKINESIA AFTER LEUCOTOMY. , 1964, Lancet.

[63]  D. Lison,et al.  Dose standardization of botulinum toxin. , 1998, Advances in neurology.

[64]  目崎 高広.  Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm : a double-blind, controlled study , 1996 .

[65]  S. Pullman,et al.  Botulinum toxin a injections for the treatment of hand tremors , 1994, Movement disorders : official journal of the Movement Disorder Society.

[66]  L. Bour,et al.  Clinical and electromyographic features of levator palpebrae superioris muscle dysfunction in involuntary eyelid closure , 1994, Movement disorders : official journal of the Movement Disorder Society.

[67]  L. Pearce,et al.  Histologic assessment of dose‐related diffusion and muscle fiber response after therapeutic botulinum a toxin injections , 1994, Movement disorders : official journal of the Movement Disorder Society.

[68]  A. Straube,et al.  Time course of distant effects of local injections of botulinum toxin , 1993, Movement disorders : official journal of the Movement Disorder Society.

[69]  P. Riederer,et al.  The possible role of iron in the etiopathology of parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[70]  L. Pearce,et al.  Botulinum a toxin for spasmodic torticollis: Multiple vs single injection points per muscle , 1992, Head & neck.

[71]  C. Ludlow,et al.  A comparison of injection techniques using botulinum toxin injection for treatment of the spasmodic dysphonias , 1992 .

[72]  J. Rivest,et al.  Writer's cramp: Treatment with botulinum toxin injections , 1991, Movement disorders : official journal of the Movement Disorder Society.

[73]  C. Yiannikas,et al.  Treatment of idiopathic spasmodic torticollis with botulinum toxin a: A double‐blind study on twenty‐three patients , 1991, Movement disorders : official journal of the Movement Disorder Society.

[74]  E. Fresnel-Elbaz,et al.  [Treatment of spasmodic dysphonia with botulinum toxin]. , 1991, Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris.

[75]  M. Brin,et al.  Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm , 1987, Movement disorders : official journal of the Movement Disorder Society.

[76]  D. Lendrem.  Statistical testing in dermatoglyphic studies. , 1985, Human heredity.